Yu-Hsin Lin

Chief Executive Officer at Belite Bio · 21 reported transactions in 1 company · latest trade Sep 8, 2026

Their trades


Belite BioBLTE	Sold $534.8K · 2,700 shares	Sep 8, 2026	S&P 500 +0.4%thru Oct 29
Belite BioBLTE	Sold $1.73M · 8,752 shares	Sep 8, 2026	S&P 500 +0.4%thru Oct 29
Belite BioBLTE	Sold $1.19M · 6,058 shares	Sep 8, 2026	S&P 500 +0.4%thru Oct 29
Belite BioBLTE	Sold $1.19M · 6,090 shares	Sep 8, 2026	S&P 500 +0.4%thru Oct 29
Belite BioBLTE	Sold $466.4K · 2,400 shares	Sep 8, 2026	S&P 500 +0.4%thru Oct 29
Belite BioBLTE	Sold $1.57M · 8,111 shares	Sep 4, 2026	S&P 500 −0.1%thru Oct 29
Belite BioBLTE	Sold $810.4K · 4,209 shares	Sep 4, 2026	S&P 500 −0.1%thru Oct 29
Belite BioBLTE	Sold $2.12M · 11,080 shares	Sep 4, 2026	S&P 500 −0.1%thru Oct 29
Belite BioBLTE	Sold $114.2K · 600 shares	Sep 4, 2026	S&P 500 −0.1%thru Oct 29
Belite BioBLTE	Sold $1.7M · 8,955 shares	Sep 4, 2026	S&P 500 −0.1%thru Oct 29

Sep 8, 2026 · BLTE

$534.8K

S&P 500 +0.4%thru Oct 29

Sep 8, 2026 · BLTE

$1.73M

S&P 500 +0.4%thru Oct 29

Sep 8, 2026 · BLTE

$1.19M

S&P 500 +0.4%thru Oct 29

Sep 8, 2026 · BLTE

$1.19M

S&P 500 +0.4%thru Oct 29

Sep 8, 2026 · BLTE

$466.4K

S&P 500 +0.4%thru Oct 29

Sep 4, 2026 · BLTE

$1.57M

S&P 500 −0.1%thru Oct 29

Sep 4, 2026 · BLTE

$810.4K

S&P 500 −0.1%thru Oct 29

Sep 4, 2026 · BLTE

$2.12M

S&P 500 −0.1%thru Oct 29

Sep 4, 2026 · BLTE

$114.2K

S&P 500 −0.1%thru Oct 29

Sep 4, 2026 · BLTE

$1.7M

S&P 500 −0.1%thru Oct 29

Newest 10 of 21 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.